Cellectis (CLLS) PT Lowered to $13 at Oppenheimer
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Price: $3.04 -2.25%
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
Oppenheimer analyst Hartaj Singh lowered the price target on Cellectis (NASDAQ: CLLS) to $13.00 (from $16.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
- SmartFinancial (SMBK) PT Raised to $60 at Benchmark on Higher Valuation
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
